Skip to main content
OpenTrials
Completed

NCT Number: NCT03229161

Interval Walking Intervention for Pregnant Women Diagnosed With Gestational Diabetes Mellitus

It is well-known that regular physical activity (PA) can improve glycemic control and physical fitness in type 2 diabetes patients. However, studies examining the effects of PA in patients with gestational diabetes mellitus (GDM) are limited. Interval walking training (IWT) is a careful type of PA consisting of repeatedly cycles of 3 min. fast and slow walking. The investigators aimed to examine, if IWT is feasible as PA intervention for GDM patients, and to examine the effects of IWT on glycemic control, PA levels and physical fitness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Danish Centre of strategic research of type 2 diabetes

Odense, 5000, Denmark

About this study

Gestational diabetes mellitus (GDM), defined as glucose intolerance and thus hyperglycemia with onset or first recognition during pregnancy, is steadily increasing in prevalence. In Denmark, the prevalence of GDM is around 2-3% of all pregnancies. GDM is associated with several adverse perinatal and maternal outcomes why early recognition and diagnosis is important. Early diagnosis and relevant treatment can prevent adverse outcomes of the baby and mother, such as macrosomia, shoulder dystocia, preeclampsia and hypoglycemia.

The glucose levels will often normalize shortly after birth; however, up to 50% of all women in Denmark diagnosed with GDM develop T2D during the first 10 years after the pregnancy, have a threefold risk of developing metabolic syndrome2 10, while the recurrence risk of developing GDM in subsequent pregnancies varies between 30-84%. Furthermore, long term increased risks for children born with macrosomia or by a mother with GDM include cardiovascular disease, obesity and T2D.

Glycemic control is a key factor in combatting the severe effects related to poorly controlled GDM. Management of GDM in Denmark consists of regular BG self-monitoring, dietary modifications, and in some cases insulin treatment. Additionally, obstetric control visits and PA advices are also a part of the standard GDM care program.

Compared to non-pregnant women, pregnant women must be more careful in relation to especially the type of PA, why supervised exercise is often recommended in order to ensure safe and correct guidance. This is a heavy economic burden, why a structured, non-supervised type of PA with low a risk of injury, possibly high compliance and continuous monitoring would be preferable. Interval walking training (IWT) is a lenient type of structured, non-supervised PA. This type of PA is associated with an improved glucose regulation in patients with T2D after 4 months of IWT 5 times weekly (60 min./session) (Karstoft et al., 2013). Due to similar metabolic dysregulations in patients with T2D and GDM, the investigators are apt to believe that IWT, if feasible, can improve glycemic control in GDM patients. Furthermore, it is obvious to believe that IWT can be implemented as regular PA in GDM patients, as one study has shown that pregnant women mostly prefer walking as a type of PA during pregnancy.

This open-label randomized controlled trial aims to enroll 20 patients randomized (1:1) to a control- (Con) or IWT-group. Both groups will follow the standard GDM care program at Odense University Hospital. Additionally, the IWT-group is prescribed three weekly IWT sessions of 40-50 minutes each for 6 weeks. Each IWT session is guided and controlled by the smartphone application 'InterWalk', which individualize the training intensity to current fitness level of the patient through an on-board fitness test.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with GDM by a 2 hour oral glucose tolerance test with a BG level of >9.00mmol/l at 2 hours
  • Danish speaking
  • >18 years of age
  • Live <20 kilometers from Odense city center

Exclusion criteria

  • Pelvic pains
  • Untreated depression
  • Walking disabilities
  • Pregnancy-related complications
  • >32 weeks

Treatment and study plan

IWT-group

Behavioral

Primary outcomes

  1. Compliance to the prescribed IWT-intervention

    Time frame: After the 6-week intervention period

    Compliance defined as adherence to the prescribed IWT-intervention

  2. Compliance to the prescribed IWT-intervention

    Time frame: After the 6-week intervention period

    Compliance defined as the quality of the the IWT sessions

Secondary outcomes

  1. Glycemic control

    Time frame: Before and after the 6-week intervention period

    Blood glucose variations measured by 48-hour continuous glucose monitoring

  2. Physical activity level

    Time frame: 7 days before and after the 6-week intervention period, and the first and last 5 days during the 6-week intervention period

    Physical activity level measured by accelerometers

  3. Physical fitness

    Time frame: Before and after the 6-week intervention period

    Physical fitness measured by the on-board fitness test in the InterWalk application and a 6-minute walking test

Other outcomes

  1. Blood pressure

    Time frame: Before and after the 6-week intervention period

    30 minutes systolic and diastolic Blood Pressure (BP) together with pulse wave velocity (PWV) was measured by using the Mobil-O Graph® PWA device. BP and PWV was measured every 3 minutes for 30 minutes in a sitting position with the assessor only being in the room during the first measurement to ensure adequate quality.

  2. Physical and mental health

    Time frame: Before and after the 6-week intervention period

    Perceived physical and mental health was measured using the SF-12 questionnaire.

  3. BMI

    Time frame: Before and after the 6-week intervention period

    Body height and body weight were objectively measured. Height was measured in an upright standing position without shoes by using a stadiometer. Weight was also measured in a standing position without shoes by using a digital scale. Height and weight was measured to the nearest 0.5 centimeter and 0.1 kilo respectively. BMI was calculated based on measured height and weight

Sponsors and collaborators

Lead sponsor

The Danish Center for Strategic Research on Type 2 Diabetes

Other

Collaborators

  • Odense University Hospital

Registry information

Official study title

Interval Walking Intervention for Pregnant Women Diagnosed With Gestational Diabetes Mellitus - a Pilot Study

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Jul 25, 2017
Registry last updated
Jul 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.